Use of Amnion on Partial Thickness Burns
Information source: The University of Texas, Galveston
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Burn
Intervention: Amnion (Biological); Amnion (Biological); Polysporin/Bacitracin/Mycostatin (Drug)
Phase: Phase 2/Phase 3
Status: Recruiting
Sponsored by: The University of Texas, Galveston Official(s) and/or principal investigator(s):
David N Herndon, MD, Principal Investigator, Affiliation: University of Texas
Overall contact:
David N Herndon, MD, Phone: 409-770-6731, Email: dherndon@utmb.edu
Summary
To determine if Amnion, used on partial thickness burn injuries would provide an improvement
in rate of healing, pain control and scarring as compared to standard medical treatments.
Clinical Details
Official title: Project Title The Treatment of Partial Thickness Burns: Treated Amnion Versus Currently in Use Topical Medications
Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Primary outcome: Length of time to 95% healing of treated burn wounds
Secondary outcome: Length of hospital stayIncidence of infection Amount of daily pain until wound is healed with different treatments. Amount of scaring with different treatments
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Partial thickness burn injury.
- >2% burn injury.
- Ages 0-100 years.
Exclusion Criteria:
- Patients not expected to survive
Locations and Contacts
David N Herndon, MD, Phone: 409-770-6731, Email: dherndon@utmb.edu
University of Texas Medical Branch, Galveston, Texas 77550, United States; Recruiting
Deb A Benjamin, RN, MSN, Phone: 409-770-6731, Email: dbenjami@utmb.edu
Carole J Miller, Phone: 409-770-6728, Email: cmiller@utmb.edu
David N Herndon, MD, Principal Investigator
Additional Information
Starting date: June 2005
Ending date: December 2014
Last updated: February 17, 2009
|
